ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing... Show more
PRPH is expected to report earnings to fall 25.00% to -11 cents per share on April 01
Q4'25
Est.
$-0.12
Q3'25
Missed
by $0.05
Q2'25
Beat
by $0.04
Q1'25
Beat
by $0.05
Q4'24
Missed
by $1.62
The last earnings report on November 19 showed earnings per share of -15 cents, missing the estimate of -10 cents. With 570.71K shares outstanding, the current market capitalization sits at 2.88M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRPH showed earnings on November 19, 2025. You can read more about the earnings report here.